A 56-Year-Old Male Farmer From China With Severe Fever With Thrombocytopenia Syndrome and Pulmonary Aspergillosis: A Case Report and Review of Literature. [PDF]
Am J Case RepLai X, Gao Q, Wu L.
europepmc +1 more source
Baloxavir outperforms oseltamivir, favipiravir, and amantadine in treating lethal influenza A(H5N1) HA clade 2.3.4.4b infection in mice. [PDF]
Nat CommunAndreev K +5 more
europepmc +1 more source
Retrospective Drug Utilization Pattern of the Use of Antivirals and Its Outcome in Hospitalized COVID-19 Patients in a Tertiary Care Hospital in Mumbai From July to October 2020. [PDF]
CureusMarolia KR, Nerurkar RP.
europepmc +1 more source
A sensitive, aqueous-based spectrofluorimetric approach for the determination of favipiravir in presence of its acid-induced degradation product. [PDF]
BMC ChemEl-Fattah MHA +3 more
europepmc +1 more source
Predictive modeling of influenza strain drugs using temperature-based topological indices and regression analysis via multi-criteria decision making techniques. [PDF]
Sci RepHayat H +3 more
europepmc +1 more source
The oral nucleoside analogue inhibitor VV251 effectively inhibits coinfection by respiratory syncytial virus and influenza A virus. [PDF]
J VirolZhang R +11 more
europepmc +1 more source
How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid-19. [PDF]
Clin Transl SciBen Ghezala I +5 more
europepmc +1 more source
Sustainable dual-drug analysis: a synchronous spectrofluorimetric approach with integrated greenness and whiteness metrics for favipiravir and levofloxacin. [PDF]
Sci RepBatakoushy HA +4 more
europepmc +1 more source
Favipiravir as a potent inhibitor of Newcastle disease virus: <i>in ovo</i> efficacy, dose-dependent toxicity, and molecular insights into RNA polymerase inhibition. [PDF]
Vet WorldSoomro NA +4 more
europepmc +1 more source